Test ID BLOD0311 CA 15-3
Synonym
CA 15-3 (Breast Cancer), BR Monitor
Specimen Type/Requirements
Gold top (serum w/gel) tube - Serum (preferred)
Red top (serum w/out gel) tube - Serum
Light Green top (Lithium Heparin w/gel) tube - Plasma
Specimen should be centrifuged and separated within 2 hours of collection.
Test may be affected by gross hemolysis, gross icterus and gross lipemia.
Specimen Volume
| Preferred Volume | 1.0 mL |
|---|---|
| Minimum Volume | 0.5 mL |
Stability/Transport
| Room Temperature | 24 hours | |
|---|---|---|
| Refrigerated | 7 days | Preferred for transport |
| Frozen | 1 year |
Performed Test Frequency
Monday - Sunday
Report Available
1 - 3 days
Additional Information
This test is used for management of Breast Cancer.
Methodology
Chemiluminescence
CA 15-3 values obtained from different assay methods cannot be used interchangeably.
Performing Lab
Sanford Laboratories Sioux Falls, Fargo, Bismarck
CPT
86300
Coverage Limitations
This test has limited coverage - please submit Commercial Insurance Patient Waiver (Non-Medicare) if applicable.
Interface Build Information
SANFORD LABORATORY INTERFACE BUILD INFORMATION
| Result Code | Result Code Description |
|---|---|
| 17083 | CA 15-3 |